Cargando…
Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol
INTRODUCTION: Fatigue is a frequent and troublesome manifestation of chronic sarcoidosis. This symptom can be debilitating and difficult to treat, with poor response to the treatment. Symptomatic management with neurostimulants, such as methylphenidate, is a possible treatment option. The use of suc...
Autores principales: | Atkins, Christopher, Fordham, Richard, Clark, Allan B, Stockl, Andrea, Jones, Andrew P, Wilson, Andrew M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719286/ https://www.ncbi.nlm.nih.gov/pubmed/29208618 http://dx.doi.org/10.1136/bmjopen-2017-018532 |
Ejemplares similares
-
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial
por: Atkins, Christopher, et al.
Publicado: (2021) -
Test-retest repeatability for fatigue assessment scale, short-form 6-dimension and King’s sarcoidosis questionnaire in people with sarcoidosis associated fatigue
por: Ferris, Rebecca, et al.
Publicado: (2023) -
Fasting and surgery timing (FaST) audit
por: El-Sharkawy, Ahmed M., et al.
Publicado: (2021) -
Randomised controlled trial of vitamin D supplementation in sarcoidosis
por: Bolland, Mark J, et al.
Publicado: (2013) -
Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression
por: Drake, Wonder P, et al.
Publicado: (2023)